Clinical Trial

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.

Study acronym: SARC-ICU
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective, observational study at the ICU of Hospital Mútua de Terrassa, running from May to December 2025. The primary goal is to determine the prevalence of sarcopenia in adult patients requiring more than 48 hours of mechanical ventilation. Sarcopenia is assessed using the SARC-F score, impedanciometry, and quadriceps ultrasound. Secondary aims include tracking the development of ICU-Acquired Weakness (ICU-AW) using the MRC score. All data is collected anonymously after obtaining informed consent.
Trial Details
NCT Number NCT07303335
Lead Sponsor Hospital Mutua de Terrassa
Conditions Sarcopenia, Critical Illness, Intensive Care (ICU) Myopathy, Body Composition Measurement, Bio-Impedance Measurements, Ultrasound Evaluation
Enrollment 100 participants
Start Date 2025-05-14
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2025-12-24